Found: 7
Select item for more details and to access through your institution.
Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer.
- Published in:
- Proteomics, 2013, v. 13, n. 14, p. 2088, doi. 10.1002/pmic.201200126
- By:
- Publication type:
- Article
Front Cover: Phosphoproteome Profiling of Isogenic Cancer Cell‐Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma.
- Published in:
- Proteomics, 2019, v. 19, n. 12, p. N.PAG, doi. 10.1002/pmic.201970101
- By:
- Publication type:
- Article
Phosphoproteome Profiling of Isogenic Cancer Cell‐Derived Exosome Reveals HSP90 as a Potential Marker for Human Cholangiocarcinoma.
- Published in:
- Proteomics, 2019, v. 19, n. 12, p. N.PAG, doi. 10.1002/pmic.201800159
- By:
- Publication type:
- Article
Quantitative proteomic analysis of the association between decreasing O-GlcNAcylation and metastasis in MCF-7 breast cancer cells.
- Published in:
- International Journal of Oncology, 2020, v. 56, n. 6, p. 1387, doi. 10.3892/ijo.2020.5022
- By:
- Publication type:
- Article
Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer.
- Published in:
- Glycoconjugate Journal, 2021, v. 38, n. 1, p. 55, doi. 10.1007/s10719-021-09978-8
- By:
- Publication type:
- Article
Aberrant O-GlcNAcylated proteins: new perspectives in breast and colorectal cancer.
- Published in:
- Frontiers in Endocrinology, 2014, v. 5, p. 1, doi. 10.3389/fendo.2014.00193
- By:
- Publication type:
- Article
Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
- Published in:
- Oncology Reports, 2018, v. 40, n. 4, p. 2193, doi. 10.3892/or.2018.6617
- By:
- Publication type:
- Article